The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

PERSPECTIVES

When will acute stroke interventions be as widely available as primary PCI?

EuroIntervention 2017;13:1269-1272. DOI: 10.4244/EIJV13I11A200

Cardiocenter, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic


Introduction

During the period from 1991 to 1993 I was working in the Netherlands where I underwent research training (Erasmus University Rotterdam) and interventional cardiology training (Thoraxcenter Zwolle). That was the fascinating period when thrombolytic treatment of acute myocardial infarction became the standard of care and the first small randomised trials demonstrated that primary percutaneous coronary intervention (p-PCI) is superior to thrombolysis in the treatment of patients presenting with acute ST-segment elevation myocardial infarction (STEMI)1-3. It took nine more years before the first national (Czech) guidelines recommended primary angioplasty (over thrombolysis) as the preferred treatment for all patients with ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
The year of memories comes to an end, but the time of achievements continues